COX5B has also been implicated as a predictor of clinical outcomes in the various cancer types, including HCC, breast cancer, glioma, gastric cancer, head and neck squamous cell carcinoma (HNSCC), and clear cell renal cell carcinoma (ccRCC) [24,29,30,31,32]. This evidence concerns the gene COX5B and gastric cancer.